Berkeley Heights, NJ, Tuesday, October 1, 2002
-
Genta Incorporated (Nasdaq: GNTA) announced today that Dr. Raymond
P. Warrell, Jr., Chairman and Chief Executive Officer, will present
an overview of the Company's strategic plans and recent highlights
at the UBS Warburg Life Sciences Conference in New York City. Dr.
Warrell's presentation will take place on Monday, October 7, 2002,
at 4:30 pm EST. A live audio webcast will be available during the
presentation via the investor relations section of the Company's
website at:
http://www.genta.com/genta/investorrelation/events.html
The presentation will be archived for 30 days.
Genta Incorporated is a biopharmaceutical company with a
diversified product portfolio that is focused on anticancer
therapy. The Company's research platform is anchored by
oligonucleotide chemistry, particularly applications of antisense
and decoy aptamer technology. Genasense
TM
, the Company"s lead compound, is being developed in collaboration
with Aventis and is currently undergoing late-stage, Phase 3
clinical testing in several clinical indications. Genta's pipeline
also comprises a portfolio of small molecules, including
gallium-containing compounds and Androgenics compounds for prostate
cancer. For more information about Genta, please visit our website
at:
http://www.genta.com/
.
